Significant genotype difference in the CYP2E1 PstI polymorphism of indigenous groups in Sabah, Malaysia with Asian and non-Asian populations.

CYP2E1 PstI polymorphism G-1259C (rs3813867) genotype distributions vary significantly among different populations and are associated with both diseases, like cancer, and adverse drug effects. To date, there have been limited genotype distributions and allele frequencies of this polymorphism reported in the three major indigenous ethnic groups (KadazanDusun, Bajau, and Rungus) in Sabah, also known as North Borneo. The aim of this study was to investigate the genotype distributions and allele frequencies of the CYP2E1 PstI polymorphism G-1259C in these three major indigenous peoples in Sabah. A total of 640 healthy individuals from the three dominant indigenous groups were recruited for this study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) at G-1259C polymorphic site of CYP2E1 gene was performed using the Pst I restriction enzyme. Fragments were analyzed using agarose gel electrophoresis and confirmed by direct sequencing. Overall, the allele frequencies were 90.3% for c1 allele and 9.7% for c2 allele. The genotype frequencies for c1/c1, c1/c2 and c2/c2 were observed as 80.9%, 18.8%, and 0.3%, respectively. A highly statistical significant difference (p<0.001) was observed in the genotype distributions between indigenous groups in Sabah with all Asian and non-Asian populations. However, among these three indigenous groups, there was no statistical significant difference (p>0.001) in their genotype distributions. The three major indigenous ethnic groups in Sabah show unique genotype distributions when compared with other populations. This finding indicates the importance of establishing the genotype distributions of CYP2E1 PstI polymorphism in the indigenous populations.

[1]  Haiyu Wang,et al.  Updated meta-analysis of the association between CYP2E1 RsaI/PstI polymorphisms and lung cancer risk in Chinese population. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[2]  Yun Liu,et al.  Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[3]  P. Wangikar,et al.  Association of N‐acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug‐induced hepatotoxicity in Western India , 2013, Journal of gastroenterology and hepatology.

[4]  A. Semlali,et al.  Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[5]  H. Galehdari,et al.  CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in iranian populations. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[6]  L. Magno,et al.  Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs , 2012, Molecular Diagnosis & Therapy.

[7]  P. Lee,et al.  Population data of six Alu insertions in indigenous groups from Sabah, Malaysia , 2012, Annals of human biology.

[8]  W. El-Rifai,et al.  Functional PstI/RsaI Polymorphism in CYP2E1 Is Associated with the Development, Progression and Poor Outcome of Gastric Cancer , 2012, PloS one.

[9]  Xueqiong Wu,et al.  NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug‐induced hepatotoxicity in Chinese patients , 2012, Clinical and experimental pharmacology & physiology.

[10]  M. Su,et al.  Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China. , 2012, Cancer epidemiology.

[11]  K. Fielding,et al.  Delays in seeking treatment for symptomatic tuberculosis in Sabah, East Malaysia: factors for patient delay. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  Z. Kayaaltı,et al.  Distribution of ADH1B, ALDH2, CYP2E1 *6, and CYP2E1 *7B genotypes in Turkish population. , 2010, Alcohol.

[13]  T. Chuang,et al.  NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  S. Gallinger,et al.  Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[15]  Qin Wang,et al.  Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males. , 2008, World journal of gastroenterology.

[16]  M. A. Ferreira,et al.  Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population. , 2007, Carcinogenesis.

[17]  I. Ember,et al.  Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. , 2007, Anticancer research.

[18]  S. Küry,et al.  Combinations of Cytochrome P450 Gene Polymorphisms Enhancing the Risk for Sporadic Colorectal Cancer Related to Red Meat Consumption , 2007, Cancer Epidemiology Biomarkers & Prevention.

[19]  T. Wobbes,et al.  Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. , 2006, Mutation research.

[20]  Danko Im,et al.  Association of CYP2E1 gene polymorphism with predisposition to cancer development. , 2005 .

[21]  Defeng Wu,et al.  Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. , 2005, Toxicology and applied pharmacology.

[22]  J. McCord Iron, free radicals, and oxidative injury. , 2004, Seminars in hematology.

[23]  J. Zhuge,et al.  Heterologous expression of human cytochrome P450 2E1 in HepG2 cell line. , 2003, World journal of gastroenterology.

[24]  P. Kandasami,et al.  Gastric cancer in Malaysia: the need for early diagnosis. , 2003, The Medical journal of Malaysia.

[25]  O. Lee,et al.  Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans , 2003, Journal of gastroenterology and hepatology.

[26]  Ricarda Thier,et al.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine , 2003, International archives of occupational and environmental health.

[27]  L. Cai,et al.  Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province. , 2001, World journal of gastroenterology.

[28]  J. Y. Park,et al.  Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. , 2001, Oral oncology.

[29]  D. Lin,et al.  Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  M. Spitz,et al.  Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. , 1997, Carcinogenesis.

[31]  M. A. García,et al.  CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians. , 1997, Age and ageing.

[32]  H. Yamazaki,et al.  In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. , 1996, The Journal of pharmacology and experimental therapeutics.

[33]  M. Fujishima,et al.  Pathological aspects of active oxygens/free radicals. , 1996, The Japanese journal of physiology.

[34]  C. J. Chen,et al.  Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. , 1995, Gastroenterology.

[35]  S. Anttila,et al.  Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review. , 1995, Gene.

[36]  G. Toda,et al.  Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to alcoholic liver cirrhosis. , 1994, The American journal of gastroenterology.

[37]  R. Rylander,et al.  Genetic polymorphism of cytochrome P4502E1 in a Swedish population , 1993, FEBS letters.

[38]  R. Kanamaru,et al.  Human cytochrome P450IIE1 gene: DraI polymorphism and susceptibility to cancer. , 1992, The Tohoku journal of experimental medicine.

[39]  B. Lakkakula,et al.  Functional PstI/RsaI polymorphisms in the CYP2E1 gene among south Indian populations. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[40]  N. Andreollo,et al.  Polymorphisms of GSTP 1 and GSTT 1 , but not of CYP 2 A 6 , CYP 2 E 1 or GSTM 1 , modify the risk for esophageal cancer in a western population , 2007 .

[41]  V. Haufroid,et al.  Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene , 2002, International archives of occupational and environmental health.

[42]  M. Spitz,et al.  Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  J. George,et al.  Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. , 1998, Seminars in hematology.

[44]  M. Boutin,et al.  Indigenous groups of Sabah : an annotated bibliography of linguistic and anthropological sources , 1984 .